CRO Inotiv has completed the sale of its business in Israel, which it described as part of the site optimisation plan for its Research Models & Services segment that it launched last year. The buyer was not named. Further assets remain for sale, which have been closed as part of the process.
Amyris and some of its US domestic subsidiaries have begun voluntary Chapter 11 proceedings in the US Bankruptcy Court for the District of Delaware as part of an operational and financial restructuring. This process does not affect its subsidiaries outside the USA.
ICL has held the groundbreaking ceremony for a $400 million, 13,000 m2, 30,000 tones/year battery materials manufacturing facility at its Carondolet site at St Louis, Missouri. Present at the event on 8 August were Secretary of Energy Jennifer M. Granholm, whose department granted $197 million towards building the facility under the Investing in America agenda, and Missouri governor Mike Parson.
Minafin, owner of Minakem, Pennakem, Minagro and related brands, has revealed that it acquired Montréal-based Delmar in July. Terms were not disclosed. Delmar’s site, which will be rebranded Minafin Montréal, employs 100 and is approved by the US FDA and other regulatory agencies for API manufacture
Kemira president and CEO Jari Rosendal died after a short illness on 31 July. He was 58. The company had announced that he had gone on sick leave on 11 July and a week later said that he would step down by 2024 at the latest. CFO Petri Castrén is acting as interim president and CEO while a successor is sought.
Tom McEleney, product marketing manager at ASCO and Paul Bristow, global product manager at TopWorx, look at how digital transformation technologies can improve predictive maintenance, reduce operating costs and improve safety and sustainability in speciality chemical plants
Members of the Sustainable Markets Initiative Health Systems Task Force have published an open letter to suppliers in the supply chain, asking them to commit to joining the initiative and working towards climate and sustainability targets. The CEOs of AstraZeneca, GSK, Merck& Co., Novo Nordisk, Sanofi and Samsung Biologics, and the chairman of Roche all signed it.
